BioMedReports.com Articles

Categories

 



Active Stocks: AbbVie, Digirad Corp, ZIOPHARM Oncology, Aegerion Pharmaceuticals, Sarepta Therapeutics

Written by David Fowler   
Friday, 31 October 2014 15:48

U.S. stocks surged Friday, with the buy cheap propecia Dow hitting an intraday record, joining a rally in Asian and cost cialis European shares that was spurred by the Bank of Japan’s decision to unexpectedly expand its stimulus measures.

Read more...
 

Active Stocks: pSivida, Galena Biopharma, Cytokinetics, Epizyme, Alexza Pharmaceuticals

Written by Josh Gee   
Monday, 27 October 2014 16:03

Stocks wavered around the unchanged mark in afternoon trade Monday, as investors paused following the biggest weekly gains for major indexes in more than a year.
Read more...
 

Active Stocks: Amgen, Alkermes, Nanosphere, Biogen Idec, Regulus Therapeutics

Written by Josh Gee   
Wednesday, 22 October 2014 15:39

U.S. stocks turned lower in afternoon trading on Wednesday, with major indexes erasing earlier gains as a shooting at the Canadian parliament unnerved investors and where can i buy priligy Boeing and buy flagyl 500mg online Biogen sold off following results.

Read more...
 

Active Stocks: Advaxis, DexCom, Cytokinetics, Valeant Pharmaceuticals, New Link Genetics

Written by Josh Gee   
Monday, 20 October 2014 14:38

U.S. stocks moved mostly higher Monday following a turbulent week. IBM fell sharply after reporting results that missed investors' expectations, pulling the Dow Jones industrial average lower.

Read more...
 

Active Stocks: Merck & Co, OncoGenex Pharmaceuticals, Ibio Inc, Orasure, AbbVie Inc

Written by Marilyn Mullen   
Thursday, 16 October 2014 17:31

U.S. stocks returned to the red Thursday afternoon, after clawing back from sharp early losses in a day of seesaw trading.

Read more...
 

Active Stocks: Aratana Therapeutics, Protalix BioTherapeutics, Cellceutix Corp, Sharps Compliance, Alnylam

Written by David Fowler   
Monday, 13 October 2014 18:20

U.S. stocks slumped, with the Standard & Poor’s 500 Index falling below its 200-day average, as investors weighed prospects for Federal Reserve interest rate increases and viagra generic slowing global economic growth.

Read more...
 
<< Start < Prev 1 > >>

Page 1 of 2

Newsletter

BioMedReports Juno Signs $1 Billion Development Pact With Celgene; Medical Marijuana Announces Investment in AXIM: Below is ... http://t.co/KS1WMVTtuH
13hreplyretweetfavorite
BioMedReports Edited Transcript of MNKD presentation 24-Jun-15 1:30pm GMT... http://t.co/sPjrXt64mP